Indian J Med Microbiol Close
 

Figure 4: Expression of LC3-II in infected-cells detected by Western blotting. RAPA-treated MEFs, WT-MEFs and Atg5-/-MEFs infected by ST10, ST8 and SR-11 at 1 and 3 h. LC3-II expressed in WT-MEFs infected by ST10 and RAPA-treated WT-MEFs infected by STsub>10, ST8 as well as SR-11 at 1 h (a) and 3 h (b). The expression of LC3-II in RAPA-treated WT-MEFs infected by ST10 was stronger than in WT-MEFs infected by ST10. LC3-II did not express in pRST98-containing strain ST8-and standard virulent strain SR-11-infected WT-MEFs and Atg5-/-MEFs infected by any bacteria

Figure 4: Expression of LC3-II in infected-cells detected by Western blotting. RAPA-treated MEFs, WT-MEFs and Atg5-/-MEFs infected by ST<sub>10</sub>, ST<sub>8</sub> and SR-11 at 1 and 3 h. LC3-II expressed in WT-MEFs infected by ST<sub>10</sub> and RAPA-treated WT-MEFs infected by STsub>10</sub>, ST<sub>8</sub> as well as SR-11 at 1 h (a) and 3 h (b). The expression of LC3-II in RAPA-treated WT-MEFs infected by ST<sub>10</sub> was stronger than in WT-MEFs infected by ST10. LC3-II did not express in pR<sub>ST98</sub>-containing strain ST8-and standard virulent strain SR-11-infected WT-MEFs and Atg5-/-MEFs infected by any bacteria